As of 2025-10-13, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (2.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -420.1%.
The range of the Relative Valuation is (1.11) - (4.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 10.7x | 6.7x |
| Forward P/E multiples | 2.7x - 10.6x | 6.6x |
| Fair Price | (1.11) - (4.42) | (2.77) |
| Upside | -228.5% - -610.2% | -420.1% |
| Date | P/E |